Allostery Investments LP Akero Therapeutics, Inc. Transaction History
Allostery Investments LP
- $69.3 Billion
- Q1 2025
A detailed history of Allostery Investments LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 18,000 shares of AKRO stock, worth $834,480. This represents 1.05% of its overall portfolio holdings.
Number of Shares
18,000Holding current value
$834,480% of portfolio
1.05%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
270Shares Held
86MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$344 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$328 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$275 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$259 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$243 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.15B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...